Cargando…
Coagulopathy in COVID-19
Hemostatic derangement is a hallmark in severe COVID-19. Markedly elevation of D-dimer and fibrinogen degradation product levels were observed in patients with severe COVID-19 higher and 71.4% of nonsurvivors met the International Society of Thrombosis and Haemostasis criteria of disseminated intrav...
Autores principales: | Lio, Ka U, Rali, Parth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104350/ https://www.ncbi.nlm.nih.gov/pubmed/33686980 http://dx.doi.org/10.4103/lungindia.lungindia_226_20 |
Ejemplares similares
-
Patent foramen ovale: Connecting dots from massive pulmonary embolism to acute ischemic stroke
por: Lio, Ka U, et al.
Publicado: (2019) -
PERT era, race‐based healthcare disparities in a large urban safety net hospital
por: Dronamraju, Veena H., et al.
Publicado: (2023) -
The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020) -
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020) -
COVID-19 coagulopathy and antiphospholipid syndrome
por: Serrano, Manuel, et al.
Publicado: (2022)